人乳头状瘤病毒相关头颈部鳞状细胞癌的研究进展

doi:10.3760/cma.j.issn.1673-422X.2015.04.013

摘要/Abstract

摘要： 近年来，人乳头状瘤病毒(HPV)相关头颈部鳞状细胞癌的发病率呈上升趋势，尤其表现在口腔鳞状细胞癌中。HPV相关头颈部鳞状细胞癌具有独特的临床特征、生物学特点及良好预后，且不暴露于吸烟、饮酒等危险因素，其生物标记物及治疗是国际的研究热点。

关键词: 头颈部肿瘤；癌, 鳞状细胞；人类；乳头状瘤病毒科

Abstract: 【Abstract】Recently, the prevalence of human papillomavirus(HPV) infection in head and neck squamous cancers has shown an upward trend, especially in the oropharynx squamous carcinoma. This subset of head and neck cancers possesses distinct clinical and laboratory features and outcome, and is particulary common in individuals who lack the traditional risk factors of tobacco and alcohol abuse. The biological markers and treatment of HPV associated head neck cancers are hot topic in current international research.

Key words: Head and neck neoplasms, Carcinoma, squamous cell, Humans, Papillomaviridae

曾汶；费继敏. 人乳头状瘤病毒相关头颈部鳞状细胞癌的研究进展[J]. 国际肿瘤学杂志, 2015, 42(4): 288-291.

Zeng-Wen-Fei-；Fei-Ji-Min. Research advances of human papillomavirus-related head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2015, 42(4): 288-291.

参考文献

［1］ Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer［J］. N Engl J Med, 2010, 363(1): 2435. ［2］ de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis［J］. Lancet Oncol, 2012, 13(6): 607615. ［3］ Blomberg M, Nielsen A, Munk C, et al. Trends in head and neck cancer incidence in Denmark, 19782007: focus on human papillomavirus associated sites［J］. Int J Cancer, 2011, 129(3): 733741. ［4］ Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States［J］. J Clin Oncol, 2011, 29(32): 42944301. ［5］ Rettig E, Kiess AP, Fakhry C. The role of sexual behavior in head and neck cancer: implications for prevention and therapy［J］. Expert Rev Anticancer Ther, 2015, 15(1): 3549. ［6］ Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 20092010［J］. JAMA, 2012, 307(7): 693703. ［7］ Saba NF, Goodman M, Ward K, et al. Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results programbased analysis［J］. Oncology, 2011, 81(1): 1220. ［8］ AlSwiahb JN, Huang CC, Fang FM, et al. Prognostic impact of pl6, p53,epidermalgrowth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nutchewing area［J］. Arch Otolaryngol Head Neck Surg, 2010, 136(5): 502508. ［9］ Nichols AC, Finkelstein DM, Faquin WC, et al. Bcl2 and human papillomavirus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer［J］. Clin Cancer Res, 2010, 16(7): 21382146. ［10］ Rietbergen MM, Snijders PJ, Beekzada D, et al. Molecular characterization of p16immunopositive but HPV DNAnegative oropharyngeal carcinomas［J］. Int J Cancer, 2014, 134(10): 23662372. ［11］ Boucek J, Mrkvan T, Chovanec M, et al. Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck［J］. J Cell Mol Med, 2010, 14(12): 426433. ［12］ Wamsom D, Light E, Thomas D, et al. Infiltrating lymphocytes and human papillomavirus16associated oropharyngeal cancer［J］. Laryngoscope, 2012, 122(1): 121127. ［13］ Lukesova E, Boucek J, Rotnaglova E, et al. High level of tregs is a positive prognostic marker in patients with HPVpositive oral and oropharyngeal squamous cell carcinomas［J］. Biomed Res Int, 2014, 2014: 303929. ［14］ Badoual C, Hans S, Merillon N, et al. PD1expressing tumorinfiltrating T cells are a favorable prognostic biomarker in HPVassociated head and neck cancer［J］. Cancer Res, 2013, 73(1): 128138. ［15］ Liang X, Zheng M, Jiang J, et al. Hypoxiainducible factor1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma［J］. Oral Oncol, 2011, 47(2): 9297. ［16］ Zhu GQ, Tang YL, Li L, et al. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma［J］. Clin Cancer Res, 2010, 16(19): 47324741. ［17］ Rahimi AS, Wilson DD, Saylor DK, et al. p16,CyclinD1,and HIF1αpredict outcomes of patients with oropharyngeal squamous cell carcinoma treated with definitive intensitymodulated radiation therapy［J］. Int J Otolaryngol, 2012, 2012: 685951. ［18］ Song X, Sturgis EM, Liu J, et al. MicroRNA variants increase the risk of HPVassociated squamous cell carcinoma of the oropharynx in never smokers［J］. PLoS One, 2013, 8(2): e56622. ［19］ Lajer CB, Nielsen FC, FriisHansen L, et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study［J］. Br J Cancer, 2011, 104(5):830840. ［20］ Hui AB, Lin A, Xu W, et al. Potentially prognostic miRNAs in HPVassociated oropharyngeal carcinoma［J］. Clin Cancer Res, 2013, 19(8): 21542162. ［21］ Guan X, Sturgis EM, Song X, et al. PremicroRNA variants predict HPV16positive tumors and survival in patients with squamous cell carcinoma of the oropharynx［J］. Cancer Lett, 2013, 330(2): 233240. ［22］ Moore EJ, Henstrom DK, Olsen KD, et al. Transoral resection of tonsillar squamous cell carcinoma［J］. Laryngoscope, 2009, 119(3): 508515. ［23］ Park YM, Lee JG, Lee WS, et al. Feasibility of transoral lateral oropharyngectomy using a robotic surgical system for tonsillar cancer［J］. Oral Oncology, 2009, 45(8): e6266. ［24］ Romanowski B. Long term protection against cervical infection with the human papillomavirus: review of currently available vaccines［J］. Hum Vaccin, 2011, 7(2): 161169. ［25］ Vermorken JB, SthlmacherWilliams J, Davidenko I, et al. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamouscell carcinoma of the head and neck (SPECTRUM): an openlabel phase 3 randomisedtrial［J］. Lancet Oncol, 2013, 14(8): 697710. ［26］ Stenner M, Yosef B, Huebbers CU, et al. Nuclear translocation of betacatenin and decreased expression of epithelial cadherin in human papillomaviruspositive tonsillar cancer: an early event in human papillomavirusrelated tumour progression?［J］. Histopathology, 2011, 58(7): 11171126.